Robuta

https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-angiotensin-ii-receptor-blocker-arb-recalls-valsartan-losartan?utm_campaign=FDA%20publishes%20a%20list%20of%20valsartan-containing%20products%20not%20part%20of%20the%20recall&utm_medium=email&utm_source=Eloqua
Stay informed on FDA updates and press announcements about recalls involving angiotensin II receptor blockers (ARBs) like valsartan and losartan. Discover key...
angiotensin ii receptorfdaupdatespressannouncements
https://www.sciencedaily.com/releases/2020/03/200323101354.htm
A possible explanation for the severe lung complications being seen in some people diagnosed with COVID-19 is proposed in a new article.
angiotensin receptor blockersace inhibitorsthe riskmayincrease
https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/11/03/16/32/cardiac-care
Anthony A. Bavry, MD, MPH, FACC
troponin iangiotensin receptorhighsensitivitycardiac
https://pubmed.ncbi.nlm.nih.gov/32030982/
The active hormone of the renin-angiotensin system (RAS), angiotensin II (Ang II), is involved in several human diseases, driving the development and clinical...
angiotensin ii receptorthe othertherapeutic target
https://pubmed.ncbi.nlm.nih.gov/12871826/
1. We studied the effect of a new angiotensin II type 1 (AT(1)) receptor antagonist, olmesartan medoxomil (olmesartan), on the fibrogenic responses in rat...
angiotensin iireceptor antagonistolmesartan medoxomiltypeimproves